SVF (Stromal Vascular Fraction) is a heterogeneous cell population obtained from adipose (fat) tissue through enzymatic or mechanical processing. It contains a mix of regenerative cells, including:
- Mesenchymal Stem Cells (MSCs) – Multipotent cells capable of differentiating into various cell types, such as bone, cartilage, and fat cells.
- Endothelial Cells & Progenitors – Essential for blood vessel formation and repair.
- Pericytes – Support vascular stability and regeneration.
- Immune Cells (e.g., Macrophages & T cells) – Contribute to tissue healing and immune modulation.
SVF is widely used in regenerative medicine due to its anti-inflammatory, immunomodulatory, and tissue-repairing properties. It is often employed in orthopaedics, aesthetics, and various therapeutic applications.
SVF banking
Following isolation, SVF is cryopreserved under cGMP-compliant conditions, ensuring long-term viability and regulatory safety. Stored in gas-phase liquid nitrogen, the cells remain readily available for future regenerative treatments, including anti-aging, orthopedics, dermatology, and immune modulation. With storage durations ranging from 5 to 25 years, SVF banking provides a personalized and scalable approach to regenerative medicine, offering a valuable resource for potential therapeutic applications.